Early studies on in-vitro and experimental activity of spiramycin: a review.

This review of spiramycin activity in vitro is based mainly on early studies. The MICs of spiramycin for common pathogenic bacteria such as staphylococci, streptococci and pneumococci are higher than those of erythromycin. Conversely, in experimental models, the activity of spiramycin is equal to or greater than that of erythromycin.

[A study by the National Reference Center for Antibiotics on inocula for antibiotic sensitivity testing].

We compared the diameters of inhibition zones obtained during antibiotic sensitivity testing using two different techniques for preparing and seeding the inoculum, i.e. photometric adjustment followed by flooding, and turbidity adjustment followed by swab streaking.

[Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].

The activity of cephalotin, cefoxitin, cefamandole, cefoperazone, cefotaxime, latamoxef, thienamycin, azthreonam, cefsulodine and ceftazidime against beta-lactamase producing strains of Enterobacteriaceae and Pseudomonas was compared by determination of 99% inhibitory concentrations. The isogenic strains studied differed by a single genetic event: mutation, gene amplification, acquisition of a high or low copy-number plasmid or of a transposon and were representative of the major known mechanisms of resistance toward beta-lactams. The results obtained indicate an overall excellent activity of ceftazidime, in particular against Pseudomonas.